平行人工膜通透性测定法(PAMPA)结合10天的多屏Caco-2细胞培养作为评估新药候选物的工具。
Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
作者信息
Masungi C, Mensch J, Van Dijck A, Borremans C, Willems B, Mackie C, Noppe M, Brewster M E
机构信息
Tibotec BVBA, Mechelen, Belgium.
出版信息
Pharmazie. 2008 Mar;63(3):194-9.
The parallel artificial membrane permeability assay (PAMPA) is extensively used for the evaluation of early drug candidates. It is high throughput, low cost and is amenable to automation. This method has been shown useful in assessing transmembrane, non-energy dependent, diffusion of drugs such that reasonable predictability with in vivo (passive) absorption is possible. Cell cultures mimicking the gastrointestinal tract such as the CACO-2 cultures have the advantage of taking into account other transport mechanism including paracellular and carrier-mediated uptake but are lower throughput and labor-intensive. In this study, the applicability of two high throughput permeability assays namely PAMPA (PSR4p, pION Inc.) and 96-well Caco-2 cell assay (MultiScreen, Millipore) were used to rank drug permeability as well as to predict passive and active drug absorption/secretion for a series of marketed drugs as well as a collection of structurally diverse drug candidates. CACO-2 cells were cultured using MultiScreen hardware over a period of 10 days with the integrity of the cells assessed using transepithelial electrical resistance (TEER) and by the ability of the monolayer to the transport a paracellular marker, sodium fluorescence. Effective permeability (Peff) data were calculated using spectrophotometric data and were binned based on a pre-defined cut-off values as either highly and poorly permeable. A comparison of a well characterized drug training set indicate at least 85% concordance between the data generated from PAMPA and Caco-2 MultiScreen. The values obtained using the MultiScreen approach were also similar to data obtained from the literature using the conventional 21-day Caco-2 cell assay. Differences between PAMPA and CACO-2 ranking were useful indicators of either drug efflux (PAMPA (Peff) > CACO-2 (Peff)) or absorptive transport (CACO-2 (Peff) > PAMPA (Peff)). These results indicate that PAMPA combined with the MultiScreen Caco-2 cell culture may be a useful high throughput screening for predicting passive diffusion and active transport of new drugs.
平行人工膜通透性测定法(PAMPA)被广泛用于早期药物候选物的评估。它具有高通量、低成本且易于自动化的特点。该方法已被证明在评估药物的跨膜、非能量依赖性扩散方面很有用,从而有可能对体内(被动)吸收进行合理预测。模拟胃肠道的细胞培养物,如Caco-2细胞培养物,具有考虑包括细胞旁和载体介导摄取在内的其他转运机制的优势,但通量较低且劳动强度大。在本研究中,使用两种高通量通透性测定法,即PAMPA(PSR4p,pION公司)和96孔Caco-2细胞测定法(MultiScreen,密理博公司)来对一系列上市药物以及一组结构多样的药物候选物的药物通透性进行排名,并预测被动和主动药物吸收/分泌。使用MultiScreen硬件培养Caco-2细胞10天,通过跨上皮电阻(TEER)以及单层细胞转运细胞旁标记物钠荧光的能力来评估细胞的完整性。使用分光光度数据计算有效渗透率(Peff)数据,并根据预先定义的截止值将其分类为高渗透性和低渗透性。对一组特征明确的药物训练集的比较表明,PAMPA和Caco-2 MultiScreen产生的数据之间至少有85%的一致性。使用MultiScreen方法获得的值也与使用传统21天Caco-2细胞测定法从文献中获得的数据相似。PAMPA和Caco-2排名之间的差异是药物外排(PAMPA(Peff)>Caco-2(Peff))或吸收性转运(Caco-2(Peff)>PAMPA(Peff))的有用指标。这些结果表明,PAMPA与MultiScreen Caco-2细胞培养相结合可能是一种用于预测新药被动扩散和主动转运的有用高通量筛选方法。